US Broker Ratings

STAAR Surgical Company (STAA) Stock Analysis: Exploring the 38.40% Potential Upside

STAAR Surgical Company (NASDAQ: STAA), a key player in the medical instruments and supplies industry, has been generating buzz among healthcare investors for its innovative ocular..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a 247% Potential Upside in Biotech Innovation

Tectonic Therapeutic, Inc. (NASDAQ: TECX) stands out in the biotechnology sector with its innovative approach to developing GPCR-targeted biologic medicines. Despite a current price of $22.86..

SIGA Technologies Inc. (SIGA) Stock Analysis: Exploring the Healthcare Innovator’s 39.94% ROE and Strategic Positioning

SIGA Technologies Inc. (NASDAQ: SIGA), a prominent player in the healthcare sector, stands out as a commercial-stage pharmaceutical company with a focus on the health security..

Bioventus Inc. (BVS) Stock Analysis: An 82.70% Potential Upside Attracts Bullish Investor Sentiment

Bioventus Inc. (BVS), a key player in the healthcare sector focusing on medical devices, is capturing attention with an exceptional potential upside of 82.70%. This Durham,..

Personalis, Inc. (PSNL) Stock Analysis: A 50% Upside Potential Amidst Strategic Innovations

For investors with a keen eye on the healthcare sector, Personalis, Inc. (NASDAQ: PSNL) presents an intriguing opportunity. Specializing in advanced cancer genomic tests and services,..

REGENXBIO Inc. (RGNX) Investor Outlook: Exploring a 202% Potential Upside with Promising Gene Therapy Innovations

REGENXBIO Inc. (NASDAQ: RGNX) is a prominent player in the biotechnology sector, with a focus on developing innovative gene therapy solutions through its proprietary NAV Technology..

Septerna, Inc. (SEPN) Stock Analysis: Biotechnology Innovator with a 38.53% Potential Upside

In the dynamic world of biotechnology, Septerna, Inc. (NASDAQ: SEPN) emerges as a compelling player with a focus on developing innovative treatments for a spectrum of..

Pharvaris N.V. (PHVS) Stock Analysis: A Promising 85% Potential Upside for Biotech Investors

Pharvaris N.V. (NASDAQ: PHVS), a Switzerland-based biotechnology firm, is making waves in the healthcare sector with its innovative approach to treating rare diseases, particularly angioedema. With..

EyePoint, Inc. (EYPT) Stock Analysis: A Potential 183% Upside in Biotech Breakthrough

Investors with an eye on the biotechnology sector might find EyePoint, Inc. (NASDAQ: EYPT) a compelling opportunity, especially given its potential upside of 183.45%. EyePoint is..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Through Challenges with a 13.62% Upside Potential

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a significant player in the healthcare sector specializing in medical care facilities, is currently trading at $8.74, which reflects a..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Exploring a 19.10% Potential Upside in the Healthcare Sector

Investors looking to explore opportunities within the biotechnology sector may find Fortrea Holdings Inc. (FTRE) intriguing, especially given its potential for a 19.10% upside based on..

Valneva SE (VALN) Stock Analysis: A 36.25% Potential Upside in the Vaccine Market

Investors with an interest in the biotechnology sector might find Valneva SE (NASDAQ: VALN) an intriguing opportunity. This French-based specialty vaccine company, with a market cap..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Biotechnology Gem with 271% Potential Upside

MeiraGTx Holdings plc (NASDAQ: MGTX), a prominent player in the biotechnology sector, is catching the attention of investors with its remarkable potential for substantial returns. The..

InnovAge Holding Corp. (INNV) Stock Analysis: What a 33% Downside Means for Investors

InnovAge Holding Corp. (NASDAQ: INNV) is at the forefront of providing comprehensive medical and ancillary services tailored for seniors who wish to live independently. Operating through..

Cronos Group Inc. (CRON) Stock Analysis: Navigating the Cannabis Sector with a 6.10% Revenue Growth

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, continues to capture investor attention..

AbCellera Biologics Inc. (ABCL): Investor Outlook Highlights a 253.72% Potential Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a pioneering player in the biotechnology sector, has become a focal point for investors looking to capitalize on its significant growth..

uniQure N.V. (QURE) Stock Analysis: A Biotech Gem with a 117% Potential Upside

uniQure N.V. (QURE), a prominent player in the biotechnology sector, stands out as a fascinating investment opportunity with a staggering potential upside of 117.08%. Operating out..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Potential Upside Amid Challenges in the Medical Device Market

Treace Medical Concepts, Inc. (NASDAQ: TMCI) is an intriguing name in the healthcare sector, specifically within the medical devices industry. The company, headquartered in Ponte Vedra,..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a 149% Potential Upside in Gene Therapy Innovations

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) stands out in the biotechnology sector with its ambitious focus on developing gene therapies for monogenic diseases of the central..

Akso Health Group (AHG) Stock Analysis: Exploring a 415.80% Revenue Growth in the Medical Distribution Sector

Investors looking for promising opportunities in the healthcare sector may find Akso Health Group (AHG) an intriguing candidate. Based in Qingdao, China, this company has carved..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds